Ondansetron Tablet, Film Coated
Product Images NDC 63850-0004

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 63850-0004). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Natco Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

8 mg Container Label (8mglabel)

Each film-coated tablet contains 10mg of ondansetron hydrochloride dihydrate, indicated for the prevention of nausea and vomiting associated with chemotherapy, radiotherapy, and surgery. The National Drug Code (NDC) of the product is 63850-0004-1, and it meets USP Dissolution Test 3. The dosage and administration information can be found in the package insert. The tablets should be stored at 20°- 25°C (68° - 77°F) in a light-resistant container. This medication is manufactured by Natco Pharma Limited in India.*

FDA Label Image

Ondan4mg30packlabel (Ondan4mglabel)

Each film-coated tablet contains 5mg of ondansetron hydrochloride dihydrate. It is a USP Ondansetron Tablet. Please refer to the package insert for proper dosage and administration. The tablets must be stored within 20-25°C (66°- 77°F) as defined by USP Controlled Room Temperature. The product meets USP Dissolution Test 3 for 30 tablets. Store the tablets in a tight, light-resistant container as outlined in the USP. The label also includes additional information about the product. The manufacturer of the product is Natco Pharma Limited.*

FDA Label Image

Ondansetron Structure (Structure1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.